Psychosocial predictors of adherence to highly active antiretroviral therapy: Practical implications

Journal of HIV/AIDS and Social Services

Volumn 6, Issue 1-2, 2007, Pages 23-37

  Gruber, Valerie A ^a   Sorensen, James L ^a   Haug, Nancy A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adherence; Compliance; Highly Active Antiretroviral Therapy psychosocial

Indexed keywords

DISEASE TREATMENT; HEALTH EDUCATION; HUMAN IMMUNODEFICIENCY VIRUS; PSYCHOLOGY; RISK FACTOR;

EID: 34247121857     PISSN: 15381501     EISSN: 1538151X     Source Type: Journal    
DOI: 10.1300/J187v06n01_03     Document Type: Review

References (36)

1. Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., Howard, A. A. et al. (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17(5), 377-81, doi:10.1046/j.1525-1497.2002.10644.x.
2. Avants, S. K., Margolin, A., Warburton, L. A., Hawkins, K. A., & Shi, J. (2001). Predictors of nonadherence to HIV-related medication regimens during methadone stabilization. American Journal of Addictions, 10(1), 69-78, doi:10.1080/105504901750160501.
3. Bangsberg, D. R., Moss, A. R., & Deeks, S. G. (2004). Paradoxes of adherence and drug resistance to HIV antiretroviral therapy. Journal of Antimicrobial Chemotherapy, 53, 696-699, doi:10.1093/jac/ dkh162.
4. Bangsberg, D. R., Hecht, F. M., Clague, H., Charlebois, E. D., Ciccarone, D., Chesney, M. et al. (2001). Provider assessment of adherence to HIV antiretroviral therapy. Journal of Acquired Immune Deficiency Syndrome, 26(5), 435-42.
5. Bangsberg, D. R., Perry, S., Charlebois, E. D., Clark, R. A., Robertson, M., Zalopa, A. R. et al. (2001). Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS, 15 9), 1181-3, doi:10.1097/00002030-200106150-00015.
6. Batki, S. L., & Selwyn, P. A. (2002). Substance abuse treatment for persons with HIV/AIDS: Treatment improvement protocol (TIP) series: 37 Rockville MD: U.S. Department of Health and Human Services, Public Health Service, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment. http://www.kap.samhsa.gov/products/manuals/tips/numerical.htm.
7. Berg, K. M., Demas, P. A., Howard, A. A., Schoenbaum, E. E., Gourevitch, M. N., & Arnsten, J. H. (2004). Gender differences in factors associated with adherence to antiretroviral therapy. Journal of General Internal Medicine, 19(11), 1111-7, doi: 10.1111/j.1525-1497.2004.30445.x.
8. Bouhnik, A. D., Chesney, M., Carrieri, P., Gallais, H., Moreau, J., Moatti, J. P. et al. (2002). Nonadherence among HIV-infected injecting drug users: The impact of social instability. Journal of Acquired Immune Deficiency Syndrome, 31(Suppl. 3), S149-53.
9. Carrieri, M. P., Chesney, M. A., Spire, B., Loundou, A., Sobel, A., Lepeu, G. et al. (2003). Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users. International Journal of Behavioral Medicine, 10(1), 1-14, doi:10.1207/ S15327558IJBM1001_01.
10. Carroll, K. M., Rounsaville, B. J., Nich, C., Gordon, L. T., Wirtz, P. W., & Gawin, F. (1994). One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects. Archives of General Psychiatry, 51 12), 989-997.
11. Chesney, M. A. (2000). Factors affecting adherence to antiretroviral therapy. Clinical Infectious Diseases, 30(Suppl. 2), S171-6, doi:10.1086/313849.
12. French, T., Weiss, L., Waters, M., Tesoriero, J., Finkelstein, R., & Agins, B. (2005). Correlation of a brief perceived stress measure with nonadherence to antiretroviral therapy over time. Journal of Acquired Immune Deficiency Syndrome, 38(5), 590-596, doi:10.1097/ 01.qai.0000135960.88543.8d.
13. Gathe, J. (2003). Adherence and potency with antiretroviral therapy: A combination for success. Journal of Acquired Immune Deficiency Syndrome, 34(Suppl. 2), S118-S122.
14. Godin, G., Cote, J., Naccache, H., Lambert, L. D., & Trottier, S. (2005). Prediction of adherence to antiretroviral therapy: A one-year longitudinal study. AIDS Care, 17(4), 493-504.
15. Golin, C. E., Liu, H., Hays, R. D., Miller, L. G., Beck, C. K., Ickovics, J. et al. (2002). A prospective study of predictors of adherence to combination antiretroviral medication. Journal of General Internal Medicine, 17(10), 756-65, doi:10.1046/ j.1525-1497.2002.11214.x.
16. Halkitis, P. N., Kutnik, A. H., & Slater, S. (2005). The social realities of adherence to protease inhibitor regimens: Substance use, health care, and psychological states. Health Psychology, 10 4), 545-58, doi:10.1177/1359105305053422.
17. Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Durvasula, R. S., Lam, M. N. et al. (2004). Medication adherence in HIV-infected adults: Effect of patient age, cognitive status, and substance abuse. AIDS, 18(Suppl. 1): S19-S25, doi:10.1097/ 00002030-200401001-00004.
18. Howard, A. A., Arnsten, J. H., Lo, Y., Vlahov, D., Rich, J. D., Schuman, P. et al. (2002). A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS, 16 16), 2175-82, doi:10.1097/00002030-200211080-00010.
19. Levine, A. J., Hinkin, C. H., Castellon, S. A., Mason, K. I., Lam, M. N., Perkins, A. et al. (2005). Variations in patterns of highly active antiretroviral therapy (HAART) adherence. AIDS and Behavior, 9 3), 355-362. doi; 0.1007/s10461-005-9009-y.
20. Liu, H., Golin, C., Miller, L., Hays, R., Beck, K., Sanandaji, S. et al. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134, 968-77.
21. Mathews, W. C., Mar-Tang, M., Ballard, C., Colwell, B., Abulhosn, K., Noonan, C. et al. (2002). Prevalence, predictors, and outcomes of early adherence after starting or changing antiretroviral therapy. AIDS Patient Care and STDs, 16(4), 167-72, doi:10.1089/ 10872910252930867.
22. McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G. et al. (1992). The fifth edition of the addiction severity index. Journal of Substance Abuse Treatment, 9(3), 199-213, doi:10.1016/0740-5472(92)90062-S.
23. Mellins, C. A., Kang, E., Leu, C. S., Havens, J. F., & Chesney, M. A. (2003). Longitudinal study of mental health and psychosocial predictors of medical treatment adherence in mothers living with HIV disease. AIDS Patient Care and STDs, 17(8), 407-16, doi:10.1089/ 108729103322277420.
24. Miller, W. R., & Rollnick, S. (2002). Motivational interviewing: Preparing people for change (2nd Ed.). New York: Guilford Press. www.motivationalinterview.org.
25. Palmer, N. B., Salcedo, J., Miller, A. L., Winiarski, M., & Arno, P. (2003). Psychiatric and social barriers to HIV medication adherence in a triply diagnosed methadone population. AIDS Patient Care and STDs, 17(12), 635-44, doi:10.1089/108729-103771928690.
26. Petry, N. M., Peirce, J. M., Stizer, M. L., Blaine, J., Roll, J. M., Cohen, A. et al. (2005). Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: A national drug abuse treatment clinical trials network study. Archives of General Psychiatry, 62(10), 1148-1156. doi: 10.1001/ archpsyc.62.10.1148.
27. Rawson, R. A., Marinelli-Casey, P., Anglin, M. D., Dickow, A., Frazier, Y., Gallagher, C. et al. (2004). A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction 99(6), 708-717. doi:10.1111/j.1360-0443.2004.00707.x.
28. Samet, J. H., Horton, N. J., Meli, S., Freedberg, K. A., & Palepu, A. (2004). Alcohol consumption and antiretroviral adherence among HIV infected persons with alcohol problems. Alcoholism: Clinical and Experimental Research, 28(4), 572-7.
29. Selwyn, P. A., Feingold, A. R., Iezza, A., Satyadeo, M., Colley, J., Torres, R. et al. (1989). Primary care for patients with human immunodeficiency virus (HIV) infection in a methadone maintenance treatment program. Annals of Internal Medicine, 111(9), 761-3.
30. Shoptaw, S., Huber, A., Peck, J., Yang, X., Liu, J., Dang, J. et al. (2006, in press). Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence. Drug and Alcohol Dependence, doi: 10.1016/j.drugalcdep.2006.03.005.
31. Spire, B., Duran, S., Souville, M., Leport, C., Raffi, F., Moatti, J. P. et al. (2002). Adherence to HAART in HIV infected patients: From a predictive to a dynamic approach. Social Science and Medicine, 54(10), 1481-96, doi:10.1016/S0277-9536(01)00125-3.
32. Stein, M. D., Rich, J. D., Maksad, J., Chen, M. H., Hu, P., Sobota, M. et al. (2000). Adherence to antiretroviral therapy among HIV-infected methadone patients: Effect of ongoing illicit drug use. American Journal of Drug and Alcohol Abuse, 26(2), 195-205, doi:10.1081/ADA-100100600.
33. Uldall, K. K., Palmer, N. B., Whetten, K., & Mellins, C. (2004). Adherence in people living with HIV/AIDS, mental illness, and chemical dependency: A review of the literature. AIDS Care, 16(Suppl. 1), S71-S96, doi:10.1080/09540120412331315277.
34. Wagner, G. J. (2002). Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries. AIDS Patient Care and STDs, 16(12), 599-608, doi:10.1089/ 108729102761882134.
35. Wagner, C., & Conners, W. (2005). MI bibliography (1983-2005). Retrieved on June 2, 2006 from the Motivational Interviewing Page sponsored by the Mid-Atlantic Addiction Technology Transfer Center, In cooperartion with the Motivation Interviewing Network of Trainers (MINT), William R. Miller, PhD, and Stephen Rollinick, PhD. at http://www.motivationalinterview.org/library/biblio.html.
36. Weaver, K. E., Llabre, M. M., Duran, R. E., Antoni, M. H., Ironson, G., Penedo, F. J. et al. (2005). A stress and coping model of medication adherence and viral load in HIV positive men and women on highly active antiretroviral therapy (HAART). Health Psychology, 24(4), 385-92, doi:10.1037/0278-6133.24.4.385.